Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.19 – $1.50
9% from low
Exchange
OTC Link
OTHER
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $0 | $0 | $0 | $0 | $0 | $1.6M |
| Cost of revenue | $7.1M | $0 | $0 | $0 | $0 | $551.0K | $1.1M |
| Gross profit | −$5.8M | $0 | $0 | $0 | $0 | −$551.0K | $490.0K |
| Gross margin | -446.7% | — | — | — | — | — | 30.3% |
| R&D | $11.1M | $8.0K | $7.2K | $13.2M | $15.8M | $13.2M | $23.9M |
| Operating income | −$25.4M | −$20.6K | −$22.8K | −$24.3M | −$34.5M | −$35.9M | −$47.7M |
| EBITDA | −$25.2M | −$20.3K | −$14.9M | −$23.6M | −$24.7M | −$32.1M | −$47.3M |
| Net income | −$24.8M | −$25.7K | −$39.8M | −$33.1M | −$35.0M | −$20.2M | −$48.8M |
| Net margin | -1917.6% | — | — | — | — | — | -3015.3% |
| EPS (diluted) | -0.19 | -1.95 | -0.56 | -122.73 | -121.29 | -0.12 | -0.12 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $16M | $-0.09 | $-0.15–$-0.06 | 1 |
| 2027 | $43M | $-0.08 | $-0.14–$-0.06 | 1 |
| 2028 | $77M | $-0.06 | $-0.09–$-0.04 | 1 |
| 2029 | $323M | $-0.07 | $-0.12–$-0.05 | 1 |
Forward consensus · source: Financial Modeling Prep
EBR SYS INC
No one on the platform currently holds EBRCZ.
No tracked institution reports a position in EBRCZ as of their last filing.
No one on the platform has traded EBRCZ yet.
| +0.00% |
| $758M |
| — |
| IVEVFInventiva S.A. | $3.59 | +0.00% | $499M | — |
| KDGTFKindstar Globalgene Technology, Inc. | $0.68 | +0.00% | $675M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.